Private equity has transformed the landscape of physician-owned practices. Pain management, anesthesiology, dermatology, ophthalmology, addiction medicine, aesthetics — almost every procedural specialty has seen a wave of consolidation. And the money is real. The multiples being offered to physician-owners are often life-changing.
But I have watched too many colleagues sign deals that looked good on paper and felt terrible eighteen months later. The pattern is almost always the same: the physician is drawn in by the headline number, does not interrogate the structure, and wakes up as an employee of their own practice with diminished autonomy and a management team that does not understand medicine.
The framework I use
When I evaluate a potential PE partnership — whether for one of my own ventures or when advising colleagues — I focus on five things:
1. Clinical autonomy preservation. This is the single most important term in the deal. If you lose the ability to make clinical decisions, hire providers you trust, and control the standard of care in your practice, no amount of money compensates for that. Get it in writing. Get it specific.
2. The management team’s track record in healthcare. Not all PE firms are the same. The ones with healthcare-specific operating partners who have actually built and scaled medical practices are fundamentally different from financial engineers who see your practice as an EBITDA line item. Ask who will be running day-to-day operations. Meet them. Evaluate them the way you would a partner.
3. The equity rollover structure. Most deals require the physician to roll a percentage of proceeds into equity in the new entity. This is where the real wealth creation happens — or does not. Understand the capital structure, the debt load, and the realistic timeline to a second liquidity event. If the firm is loading the platform with debt to finance acquisitions, your rolled equity may be worth less than you think.
4. Non-compete terms. These are often draconian in PE-backed deals. Understand exactly what you are agreeing to: geography, duration, scope. If the deal goes sideways and you want to leave, can you still practice medicine in your market?
5. Cultural alignment. This one is hard to quantify but easy to feel. Does the PE firm understand that healthcare is different from a SaaS company? Do they respect the physician-patient relationship? Are they building for sustainable growth or stripping the practice for a quick flip?
The bottom line
PE capital is not inherently good or bad — it is a tool. The right partnership can accelerate growth, professionalize operations, and give you access to resources you could never build alone. The wrong partnership can destroy what you spent a career building.
Do the diligence. Hire a healthcare M&A attorney. Talk to physicians who have been through the process with that specific firm. And never sign anything out of urgency — the best deals will wait for you to be ready.